Jeremy Bridge-Cook

[Genomadix Inc. @GenomadixInc]

Join us on January 22, 2025 at 5:00 PM (EST) for an exclusive, in-depth webinar titled "Reducing Recurrent Stroke Risk with CYP2C19 Genotype-Guided DAPT".🧠
📅 Details in the image!
📌 Registration is required
👉 Register here: https://t.co/lveBuDMWZ4
🎥 🎥 Can't attend live? No worries! Register, and you'll be contacted via email with information about the recording.
#stroke #neurotwitter #Neurology #MedTwitter #CYP2C19

[Genomadix Inc. @GenomadixInc]

Writing Group Chair Naveen Pereira, MD and Vice Chair Sharon Cresci, MD discuss the latest scientific statement released by the American Heart Association @American_Heart  "#CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy". #neurotwitter #neuroX
https://t.co/tipm8w21n6

[Jeremy Bridge-Cook @jbridgecook]

@HRHospital Can torontonians from outside your catchment area who are aged 40-54 come get vaccinated today?

[Jeremy Bridge-Cook @jbridgecook]

@TheAgenda @jm_mcgrath @DFisman The low volume of testing in Ontario is unconscionable. The countries that have done best are those that tested aggressively. Ontarians deserve to know their true risk so they can make informed choices. This is an epidemiological fight—we are fighting blind unnecessarily.